Novartis’s Sandoz Sees Pipeline Adding $3 Billion Sales by 2028
Novartis AG’s generic-drug unit Sandoz could add $3 billion in sales over the next five years from its
2023-06-08 13:54
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:28
Drug Companies Are Minting Billions on Unproven Treatments With FDA Shortcut
When Exondys 51 was approved to treat Duchenne muscular dystrophy, a deadly disease that puts kids in wheelchairs
2023-05-15 07:16